MAP Pharmaceuticals, a Mountain View, Calif., developer of reformulated drugs for inhalation, has filed to raise up to $86 million in an initial public offering.
See VentureBeat LifeSciences story here.
Trackback URL
Top Stories
- Look what iFound: iFund submissions leaked online
- News aggregator Techmeme melds algorithms and humans
- Cooliris' 3D wall gets a little more ...
- Amazon launches an iPhone app, uh where ...
- Angie's List swells with $7M for consumer ...
Recent Guest Columnists
Job Board
- Regional Vice President of Sales
at Marketing Technology Solutions (Jersey City, NJ) - More Jobs » | Post a Job »
Links
Venturebeat Writers
- Matt Marshall, Editor-in-Chief
- Dean Takahashi, Lead Writer, DigitalMedia
- Eric Eldon, Editor, DigitalMedia
- MG Siegler, Writer, DigitalMedia
- Anthony Ha, Writer, VentureBeat
- Chris Morrison, Writer, CleanTech
- For advertising, contact .
- Log in
Font Size
© 2004-2008(c) Matt Marshall. All rights reserved.Site produced by RubyRed Labs, Evan Levelle
powered by Wordpress